publication . Report . Other literature type . 2020

Statistical review of Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

Wilkinson, Jack; Dahly, Darren;
Open Access English
  • Published: 31 Mar 2020
Abstract
The following review has been prepared in collaboration with members of the MRC-NIHR Trials Methodology Research Partnership. The reviewers named above, and other, unnamed discussants of the paper, are all qualified statisticians with experience in clinical trials. Our objective is to provide a rapid review of publications, preprints and protocols from clinical trials of COVID-19 treatments, independent of journal specific review processes. We aim to provide timely, constructive, focused, clear advice aimed at improving both the research outputs under review, as well as future studies. Given our collective expertise (clinical trial statistics) our reviews focus ...
Subjects
free text keywords: Randomized Clinical Trials, COVID-19, Antiviral, Favipiravir, Arbidol
Communities
COVID-19
Download fromView all 3 versions
ZENODO
Report . 2020
Provider: ZENODO
Zenodo
Other literature type . 2020
Provider: Datacite
Zenodo
Other literature type . 2020
Provider: Datacite
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Report . Other literature type . 2020

Statistical review of Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

Wilkinson, Jack; Dahly, Darren;